1. Home
  2. EYPT vs CINT Comparison

EYPT vs CINT Comparison

Compare EYPT & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • CINT
  • Stock Information
  • Founded
  • EYPT 1987
  • CINT 1995
  • Country
  • EYPT United States
  • CINT Brazil
  • Employees
  • EYPT N/A
  • CINT N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • CINT EDP Services
  • Sector
  • EYPT Industrials
  • CINT Technology
  • Exchange
  • EYPT Nasdaq
  • CINT Nasdaq
  • Market Cap
  • EYPT 741.0M
  • CINT 803.4M
  • IPO Year
  • EYPT 2005
  • CINT 2021
  • Fundamental
  • Price
  • EYPT $11.09
  • CINT $5.29
  • Analyst Decision
  • EYPT Strong Buy
  • CINT Buy
  • Analyst Count
  • EYPT 7
  • CINT 7
  • Target Price
  • EYPT $24.29
  • CINT $7.44
  • AVG Volume (30 Days)
  • EYPT 643.4K
  • CINT 200.1K
  • Earning Date
  • EYPT 08-06-2025
  • CINT 08-13-2025
  • Dividend Yield
  • EYPT N/A
  • CINT N/A
  • EPS Growth
  • EYPT N/A
  • CINT 34.66
  • EPS
  • EYPT N/A
  • CINT 0.25
  • Revenue
  • EYPT $51,898,000.00
  • CINT $452,826,000.00
  • Revenue This Year
  • EYPT N/A
  • CINT $11.04
  • Revenue Next Year
  • EYPT N/A
  • CINT $13.25
  • P/E Ratio
  • EYPT N/A
  • CINT $21.44
  • Revenue Growth
  • EYPT 2.99
  • CINT 1.02
  • 52 Week Low
  • EYPT $3.91
  • CINT $4.42
  • 52 Week High
  • EYPT $13.99
  • CINT $8.04
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.85
  • CINT 45.54
  • Support Level
  • EYPT $10.22
  • CINT $4.86
  • Resistance Level
  • EYPT $11.28
  • CINT $5.70
  • Average True Range (ATR)
  • EYPT 0.71
  • CINT 0.24
  • MACD
  • EYPT 0.04
  • CINT 0.00
  • Stochastic Oscillator
  • EYPT 89.89
  • CINT 51.19

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About CINT CI&T Inc

CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

Share on Social Networks: